(S)-4’-Hydroxy warfarin
CAS: 68407-05-6
Ref. 3D-TCA40705
| 1mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado |
Informação sobre produto
Nome:
(S)-4’-Hydroxy warfarin
Sinónimos:
- 2H-1-Benzopyran-2-one, 4-hydroxy-3-[1-(4-hydroxyphenyl)-3-oxobutyl]-, (S)-
- 4-Hydroxy-3-[(1S)-1-(4-hydroxyphenyl)-3-oxobutyl]-2H-1-benzopyran-2-one
- (S)-4′-Hydroxywarfarin
- 4′-Hydroxy-S-warfarin
- 2H-1-Benzopyran-2-one, 4-hydroxy-3-[(1S)-1-(4-hydroxyphenyl)-3-oxobutyl]-
Descrição:
Warfarin is a coumarin-type anticoagulant that inhibits the synthesis of vitamin K-dependent clotting factors, which are necessary for blood coagulation. It is also used as an anticancer agent in animals and humans. Warfarin inhibits the activity of cytochrome P450 (CYP) enzymes, including CYP2C9, CYP2C19, and CYP3A4. This inhibition may lead to drug interactions with other drugs metabolized by these enzymes. Warfarin has been shown to have anticancer effects in both cell culture and animal models. The anticancer effect of warfarin is due to its ability to inhibit the growth of cancer cells by interfering with the synthesis of DNA and RNA.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
324.3 g/mol
Fórmula:
C19H16O5
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
